Global Healthcare Clinical Trial Management System Market
Global Healthcare Clinical Trial Management System Market

Healthcare Clinical Trial Management System Comprehensive Study by Type (Enterprise CTMS, Site CTMS), Application (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CRO), Medical Device Companies, Other), Components (Software, Hardware, Service), Delivery Mode (Cloud-based (SaaS) CTMS, Licensed Enterprise (On Premise) CTMS, Web-based (Hosted) CTMS) Players and Region - Global Market Outlook to 2025

Healthcare Clinical Trial Management System Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Mar 2020 Edition 205 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Healthcare Clinical Trial Management System Market Overview:
Healthcare clinical trial management system is a software system which is used to manage clinical trials information in clinical research. The consistent growth of healthcare IT, high R&D expenditure by life science and clinical research companies and organizations and increasing adoption of CTMS solutions is the lucrative opportunity in the growth of the very market. Some of the key players profiled in the study are Oracle Corporation (United States), Medidata Solutions, Inc. (United States), PAREXEL International Corporation (United States), Bioclinica (United States), Bio-Optronics, Inc. (United States), IBM Corporation (United States), Bioclinica (United States), MedNet Solutions Inc. (United States), ArisGlobal LLC (United States) and DSG, Inc. (United States).

On the basis of geography, the market of Healthcare Clinical Trial Management System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Components, the sub-segment i.e. Software will boost the Healthcare Clinical Trial Management System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Delivery Mode, the sub-segment i.e. Cloud-based (SaaS) CTMS will boost the Healthcare Clinical Trial Management System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Number of Partnerships between Biopharma Companies and Contract Research Organizations (CROs)
  • Availability of Advanced Healthcare Clinical Trial Management System Solutions Globally

Market Trend
  • Adoption of Platform-as-a-Service (PaaS) and Mobile Computing
  • The Growth in Number of Clinical Trials by Market Players

Restraints
  • Budget Constraints in Various Developing Economies
  • Limited Awareness among Researchers about the Advantages of Healthcare CTMS Solutions

Opportunities
  • Surged in Number of Outsourcing of Clinical Trial Processes by Industrial Researchers to Asian Countries CROs
  • Increasing Government Funding & Grants to Support Clinical Trials and Surging Customer Base for Healthcare CTMS Solutions

Challenges
  • Lack of Skilled Professionals in Developing Nations




In the current scenario, various market players are increasingly outsourcing their clinical trials to CROs to reduce the cost and time of the entire process, improve their global reach and extend their expertise. Thus, an increasing number in partnerships between biopharma companies and CROs are also expected to increase the adoption of these systems in the upcoming years.

Target Audience:
Pharmaceutical/Biopharmaceutical Companies, Healthcare IT Service Providers, Research and Development (R&D) Companies, Clinical Research Organizations, Medical Device Manufacturing Companies, Academic Medical Centres/Universities/Hospitals and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Healthcare Clinical Trial Management System market on the basis of product [Enterprise CTMS and Site CTMS] , application [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CRO), Medical Device Companies and Other], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Healthcare Clinical Trial Management System market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Healthcare Clinical Trial Management System industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Healthcare Clinical Trial Management System market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Enterprise CTMS
  • Site CTMS
By Application
  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations (CRO)
  • Medical Device Companies
  • Other
By Components
  • Software
  • Hardware
  • Service

By Delivery Mode
  • Cloud-based (SaaS) CTMS
  • Licensed Enterprise (On Premise) CTMS
  • Web-based (Hosted) CTMS

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Partnerships between Biopharma Companies and Contract Research Organizations (CROs)
      • 3.2.2. Availability of Advanced Healthcare Clinical Trial Management System Solutions Globally
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals in Developing Nations
    • 3.4. Market Trends
      • 3.4.1. Adoption of Platform-as-a-Service (PaaS) and Mobile Computing
      • 3.4.2. The Growth in Number of Clinical Trials by Market Players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare Clinical Trial Management System, by Type, Application, Components, Delivery Mode and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Healthcare Clinical Trial Management System (Value)
      • 5.2.1. Global Healthcare Clinical Trial Management System by: Type (Value)
        • 5.2.1.1. Enterprise CTMS
        • 5.2.1.2. Site CTMS
      • 5.2.2. Global Healthcare Clinical Trial Management System by: Application (Value)
        • 5.2.2.1. Pharmaceutical and Biopharmaceutical Companies
        • 5.2.2.2. Contract Research Organizations (CRO)
        • 5.2.2.3. Medical Device Companies
        • 5.2.2.4. Other
      • 5.2.3. Global Healthcare Clinical Trial Management System by: Components (Value)
        • 5.2.3.1. Software
        • 5.2.3.2. Hardware
        • 5.2.3.3. Service
      • 5.2.4. Global Healthcare Clinical Trial Management System by: Delivery Mode (Value)
        • 5.2.4.1. Cloud-based (SaaS) CTMS
        • 5.2.4.2. Licensed Enterprise (On Premise) CTMS
        • 5.2.4.3. Web-based (Hosted) CTMS
      • 5.2.5. Global Healthcare Clinical Trial Management System Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Healthcare Clinical Trial Management System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Oracle Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medidata Solutions, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. PAREXEL International Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bioclinica (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Optronics, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. IBM Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bioclinica (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MedNet Solutions Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ArisGlobal LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. DSG, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Healthcare Clinical Trial Management System Sale, by Type, Application, Components, Delivery Mode and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Healthcare Clinical Trial Management System (Value)
      • 7.2.1. Global Healthcare Clinical Trial Management System by: Type (Value)
        • 7.2.1.1. Enterprise CTMS
        • 7.2.1.2. Site CTMS
      • 7.2.2. Global Healthcare Clinical Trial Management System by: Application (Value)
        • 7.2.2.1. Pharmaceutical and Biopharmaceutical Companies
        • 7.2.2.2. Contract Research Organizations (CRO)
        • 7.2.2.3. Medical Device Companies
        • 7.2.2.4. Other
      • 7.2.3. Global Healthcare Clinical Trial Management System by: Components (Value)
        • 7.2.3.1. Software
        • 7.2.3.2. Hardware
        • 7.2.3.3. Service
      • 7.2.4. Global Healthcare Clinical Trial Management System by: Delivery Mode (Value)
        • 7.2.4.1. Cloud-based (SaaS) CTMS
        • 7.2.4.2. Licensed Enterprise (On Premise) CTMS
        • 7.2.4.3. Web-based (Hosted) CTMS
      • 7.2.5. Global Healthcare Clinical Trial Management System Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare Clinical Trial Management System: by Type(USD Million)
  • Table 2. Healthcare Clinical Trial Management System Enterprise CTMS , by Region USD Million (2014-2019)
  • Table 3. Healthcare Clinical Trial Management System Site CTMS , by Region USD Million (2014-2019)
  • Table 4. Healthcare Clinical Trial Management System: by Application(USD Million)
  • Table 5. Healthcare Clinical Trial Management System Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2014-2019)
  • Table 6. Healthcare Clinical Trial Management System Contract Research Organizations (CRO) , by Region USD Million (2014-2019)
  • Table 7. Healthcare Clinical Trial Management System Medical Device Companies , by Region USD Million (2014-2019)
  • Table 8. Healthcare Clinical Trial Management System Other , by Region USD Million (2014-2019)
  • Table 9. Healthcare Clinical Trial Management System: by Components(USD Million)
  • Table 10. Healthcare Clinical Trial Management System Software , by Region USD Million (2014-2019)
  • Table 11. Healthcare Clinical Trial Management System Hardware , by Region USD Million (2014-2019)
  • Table 12. Healthcare Clinical Trial Management System Service , by Region USD Million (2014-2019)
  • Table 13. Healthcare Clinical Trial Management System: by Delivery Mode(USD Million)
  • Table 14. Healthcare Clinical Trial Management System Cloud-based (SaaS) CTMS , by Region USD Million (2014-2019)
  • Table 15. Healthcare Clinical Trial Management System Licensed Enterprise (On Premise) CTMS , by Region USD Million (2014-2019)
  • Table 16. Healthcare Clinical Trial Management System Web-based (Hosted) CTMS , by Region USD Million (2014-2019)
  • Table 17. South America Healthcare Clinical Trial Management System, by Country USD Million (2014-2019)
  • Table 18. South America Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 19. South America Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 20. South America Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 21. South America Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 22. Brazil Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 23. Brazil Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 24. Brazil Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 25. Brazil Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 26. Argentina Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 27. Argentina Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 28. Argentina Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 29. Argentina Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 30. Rest of South America Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 31. Rest of South America Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 32. Rest of South America Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 33. Rest of South America Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 34. Asia Pacific Healthcare Clinical Trial Management System, by Country USD Million (2014-2019)
  • Table 35. Asia Pacific Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 36. Asia Pacific Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 37. Asia Pacific Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 38. Asia Pacific Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 39. China Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 40. China Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 41. China Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 42. China Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 43. Japan Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 44. Japan Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 45. Japan Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 46. Japan Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 47. India Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 48. India Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 49. India Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 50. India Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 51. South Korea Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 52. South Korea Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 53. South Korea Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 54. South Korea Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 55. Taiwan Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 56. Taiwan Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 57. Taiwan Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 58. Taiwan Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 59. Australia Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 60. Australia Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 61. Australia Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 62. Australia Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 63. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 64. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 65. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 66. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 67. Europe Healthcare Clinical Trial Management System, by Country USD Million (2014-2019)
  • Table 68. Europe Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 69. Europe Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 70. Europe Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 71. Europe Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 72. Germany Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 73. Germany Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 74. Germany Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 75. Germany Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 76. France Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 77. France Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 78. France Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 79. France Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 80. Italy Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 81. Italy Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 82. Italy Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 83. Italy Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 84. United Kingdom Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 85. United Kingdom Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 86. United Kingdom Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 87. United Kingdom Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 88. Netherlands Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 89. Netherlands Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 90. Netherlands Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 91. Netherlands Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 92. Rest of Europe Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 93. Rest of Europe Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 94. Rest of Europe Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 95. Rest of Europe Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 96. MEA Healthcare Clinical Trial Management System, by Country USD Million (2014-2019)
  • Table 97. MEA Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 98. MEA Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 99. MEA Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 100. MEA Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 101. Middle East Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 102. Middle East Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 103. Middle East Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 104. Middle East Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 105. Africa Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 106. Africa Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 107. Africa Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 108. Africa Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 109. North America Healthcare Clinical Trial Management System, by Country USD Million (2014-2019)
  • Table 110. North America Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 111. North America Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 112. North America Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 113. North America Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 114. United States Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 115. United States Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 116. United States Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 117. United States Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 118. Canada Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 119. Canada Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 120. Canada Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 121. Canada Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 122. Mexico Healthcare Clinical Trial Management System, by Type USD Million (2014-2019)
  • Table 123. Mexico Healthcare Clinical Trial Management System, by Application USD Million (2014-2019)
  • Table 124. Mexico Healthcare Clinical Trial Management System, by Components USD Million (2014-2019)
  • Table 125. Mexico Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2014-2019)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Healthcare Clinical Trial Management System: by Type(USD Million)
  • Table 137. Healthcare Clinical Trial Management System Enterprise CTMS , by Region USD Million (2020-2025)
  • Table 138. Healthcare Clinical Trial Management System Site CTMS , by Region USD Million (2020-2025)
  • Table 139. Healthcare Clinical Trial Management System: by Application(USD Million)
  • Table 140. Healthcare Clinical Trial Management System Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2020-2025)
  • Table 141. Healthcare Clinical Trial Management System Contract Research Organizations (CRO) , by Region USD Million (2020-2025)
  • Table 142. Healthcare Clinical Trial Management System Medical Device Companies , by Region USD Million (2020-2025)
  • Table 143. Healthcare Clinical Trial Management System Other , by Region USD Million (2020-2025)
  • Table 144. Healthcare Clinical Trial Management System: by Components(USD Million)
  • Table 145. Healthcare Clinical Trial Management System Software , by Region USD Million (2020-2025)
  • Table 146. Healthcare Clinical Trial Management System Hardware , by Region USD Million (2020-2025)
  • Table 147. Healthcare Clinical Trial Management System Service , by Region USD Million (2020-2025)
  • Table 148. Healthcare Clinical Trial Management System: by Delivery Mode(USD Million)
  • Table 149. Healthcare Clinical Trial Management System Cloud-based (SaaS) CTMS , by Region USD Million (2020-2025)
  • Table 150. Healthcare Clinical Trial Management System Licensed Enterprise (On Premise) CTMS , by Region USD Million (2020-2025)
  • Table 151. Healthcare Clinical Trial Management System Web-based (Hosted) CTMS , by Region USD Million (2020-2025)
  • Table 152. South America Healthcare Clinical Trial Management System, by Country USD Million (2020-2025)
  • Table 153. South America Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 154. South America Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 155. South America Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 156. South America Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 157. Brazil Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 158. Brazil Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 159. Brazil Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 160. Brazil Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 161. Argentina Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 162. Argentina Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 163. Argentina Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 164. Argentina Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 165. Rest of South America Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 166. Rest of South America Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 167. Rest of South America Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 168. Rest of South America Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 169. Asia Pacific Healthcare Clinical Trial Management System, by Country USD Million (2020-2025)
  • Table 170. Asia Pacific Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 171. Asia Pacific Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 172. Asia Pacific Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 173. Asia Pacific Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 174. China Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 175. China Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 176. China Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 177. China Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 178. Japan Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 179. Japan Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 180. Japan Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 181. Japan Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 182. India Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 183. India Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 184. India Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 185. India Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 186. South Korea Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 187. South Korea Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 188. South Korea Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 189. South Korea Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 190. Taiwan Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 191. Taiwan Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 192. Taiwan Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 193. Taiwan Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 194. Australia Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 195. Australia Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 196. Australia Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 197. Australia Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 198. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 199. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 200. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 201. Rest of Asia-Pacific Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 202. Europe Healthcare Clinical Trial Management System, by Country USD Million (2020-2025)
  • Table 203. Europe Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 204. Europe Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 205. Europe Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 206. Europe Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 207. Germany Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 208. Germany Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 209. Germany Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 210. Germany Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 211. France Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 212. France Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 213. France Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 214. France Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 215. Italy Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 216. Italy Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 217. Italy Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 218. Italy Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 219. United Kingdom Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 220. United Kingdom Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 221. United Kingdom Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 222. United Kingdom Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 223. Netherlands Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 224. Netherlands Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 225. Netherlands Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 226. Netherlands Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 227. Rest of Europe Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 228. Rest of Europe Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 229. Rest of Europe Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 230. Rest of Europe Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 231. MEA Healthcare Clinical Trial Management System, by Country USD Million (2020-2025)
  • Table 232. MEA Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 233. MEA Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 234. MEA Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 235. MEA Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 236. Middle East Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 237. Middle East Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 238. Middle East Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 239. Middle East Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 240. Africa Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 241. Africa Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 242. Africa Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 243. Africa Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 244. North America Healthcare Clinical Trial Management System, by Country USD Million (2020-2025)
  • Table 245. North America Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 246. North America Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 247. North America Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 248. North America Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 249. United States Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 250. United States Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 251. United States Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 252. United States Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 253. Canada Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 254. Canada Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 255. Canada Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 256. Canada Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 257. Mexico Healthcare Clinical Trial Management System, by Type USD Million (2020-2025)
  • Table 258. Mexico Healthcare Clinical Trial Management System, by Application USD Million (2020-2025)
  • Table 259. Mexico Healthcare Clinical Trial Management System, by Components USD Million (2020-2025)
  • Table 260. Mexico Healthcare Clinical Trial Management System, by Delivery Mode USD Million (2020-2025)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare Clinical Trial Management System: by Type USD Million (2014-2019)
  • Figure 5. Global Healthcare Clinical Trial Management System: by Application USD Million (2014-2019)
  • Figure 6. Global Healthcare Clinical Trial Management System: by Components USD Million (2014-2019)
  • Figure 7. Global Healthcare Clinical Trial Management System: by Delivery Mode USD Million (2014-2019)
  • Figure 8. South America Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 9. Asia Pacific Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 10. Europe Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 11. MEA Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 12. North America Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 13. Global Healthcare Clinical Trial Management System share by Players 2019 (%)
  • Figure 14. Global Healthcare Clinical Trial Management System share by Players (Top 3) 2019(%)
  • Figure 15. Global Healthcare Clinical Trial Management System share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Oracle Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Oracle Corporation (United States) Revenue: by Geography 2019
  • Figure 19. Medidata Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Medidata Solutions, Inc. (United States) Revenue: by Geography 2019
  • Figure 21. PAREXEL International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. PAREXEL International Corporation (United States) Revenue: by Geography 2019
  • Figure 23. Bioclinica (United States) Revenue, Net Income and Gross profit
  • Figure 24. Bioclinica (United States) Revenue: by Geography 2019
  • Figure 25. Bio-Optronics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bio-Optronics, Inc. (United States) Revenue: by Geography 2019
  • Figure 27. IBM Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. IBM Corporation (United States) Revenue: by Geography 2019
  • Figure 29. Bioclinica (United States) Revenue, Net Income and Gross profit
  • Figure 30. Bioclinica (United States) Revenue: by Geography 2019
  • Figure 31. MedNet Solutions Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. MedNet Solutions Inc. (United States) Revenue: by Geography 2019
  • Figure 33. ArisGlobal LLC (United States) Revenue, Net Income and Gross profit
  • Figure 34. ArisGlobal LLC (United States) Revenue: by Geography 2019
  • Figure 35. DSG, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. DSG, Inc. (United States) Revenue: by Geography 2019
  • Figure 37. Global Healthcare Clinical Trial Management System: by Type USD Million (2020-2025)
  • Figure 38. Global Healthcare Clinical Trial Management System: by Application USD Million (2020-2025)
  • Figure 39. Global Healthcare Clinical Trial Management System: by Components USD Million (2020-2025)
  • Figure 40. Global Healthcare Clinical Trial Management System: by Delivery Mode USD Million (2020-2025)
  • Figure 41. South America Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 42. Asia Pacific Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 43. Europe Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 44. MEA Healthcare Clinical Trial Management System Share (%), by Country
  • Figure 45. North America Healthcare Clinical Trial Management System Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Oracle Corporation (United States)
  • Medidata Solutions, Inc. (United States)
  • PAREXEL International Corporation (United States)
  • Bioclinica (United States)
  • Bio-Optronics, Inc. (United States)
  • IBM Corporation (United States)
  • Bioclinica (United States)
  • MedNet Solutions Inc. (United States)
  • ArisGlobal LLC (United States)
  • DSG, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation